People who are looking for relief from chronic pain or dysfunction associated with adhesions often do not know where to turn for answers, especially if they are trying to avoid surgery and medications and achieve a natural solution with physical therapy. Here, we hope to clear away misconceptions and confusion about three types of techniques: Myofascial release (MFR), visceral manipulation (VM), and Clear Passage (CP). Although each technique has its own history, merits, and individual traits, the specific methods, standards, and outcomes of Clear Passage set it apart as the preferred technique for treating adhesions wherever they form in the body, especially when it comes to certain women’s health conditions, female infertility, and life-threatening small bowel obstructions. Here are the details as of this writing (May 2022). Myofascial release is generally a deep structural manual therapy developed by John F. Barnes, PT as a method to treat restrictions in the muscles (myo) and fascia (fascial) of the human body. A PubMed (NIH) literature search found several case studies that report MFR for treating musculoskeletal pain (notably low back and ankle pain). None examined its use for patients with abdominal or pelvic conditions. Many providers claim to perform myofascial release. We are most comfortable recommending an expert-level Barnes trained therapist for chronic musculoskeletal pain. Visceral manipulation is generally a very light manual therapy initially developed to treat viscera (organs) in the body. Its founder, Jean Pierre Barral, D.O. often suggests conducting a single 60-minute VM session every three weeks. He feels that a site-specific application of VM can be “the pebble that starts the avalanche” in healing the body of physical restrictions. A PubMed (NIH) literature search conducted in May 2022 revealed five studies of VM, most for neck and back pain. Despite its name, no study exists that examines VM for treating organs in humans. Clear Passage is a therapy developed over 30+ years as a method to decrease specific internal scars called adhesions wherever they form in the body. CP was initially developed by Belinda Wurn, PT and Larry Wurn, LMT as a treatment for chronic pain and dysfunction in patients with problems caused or exacerbated by adhesions. This pain was often labeled ‘unexplained’ because adhesions do not appear on diagnostic tests. Over time, the therapy has expanded with peer-reviewed studies examining its effectiveness treating several women’s health conditions, female infertility, and life-threatening small bowel obstructions. CP is a very site-specific soft tissue therapy. It is often quite deep and sometimes lighter, but CP is always focused on decreasing adhesions – a significant problem for many patients and their doctors. An aspect of the therapy considered pioneering by some physicians is its ability to replace a planned surgery. In doing so, CP helps decrease the risks of anesthesia, surgery and post-surgical adhesions.